[The comparison of short-term efficacies between decitabine and HA regimen for MDS/AML patients].
Wei-Feng
WF
Chen
Fen
F
Huang
Jie
J
Zha
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001374:Azacitidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077209:Decitabine; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000209:etiology*; D008297:Male; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000473:pathology; D016896:Treatment Outcome
D000077209:Decitabine; D001374:Azacitidine